InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Gibson Christopher, 董事长兼首席执行官. Officer active across 2 companies, notably Recursion Pharmaceuticals, INC.. Aggregated, 110 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 21 November 2021. The latest transaction was disclosed on 22 May 2026 (C). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gibson Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报110 总计
40,000 股0Class A Common StockSEC:0001856369-26-000019:0
40,000 股@ US$3.080.0075% mcap2.3% 占其流量Class A Common StockSEC:0001856369-26-000019:1
40,000 股0Class A Common StockSEC:0001856369-26-000013:0
40,000 股@ US$3.610.0069% mcap2.6% 占其流量Class A Common StockSEC:0001856369-26-000013:1
57,473 股0Common StockSEC:0001856369-26-000010:0
40,000 股0Class A Common StockSEC:0001856369-26-000008:0
40,000 股@ US$3.102.2% 占其流量Class A Common StockSEC:0001856369-26-000008:1
40,000 股0Class A Common StockSEC:0001601830-26-000052:0
20,000 股0Class A Common StockSEC:0001601830-26-000049:0
53,913 股0Common StockSEC:0001299130-26-000050:0
27,265 股@ US$3.491.0% 占其流量Class A Common StockSEC:0001601830-26-000021:0
40,000 股0Class A Common StockSEC:0001601830-26-000008:0
40,000 股0Class A Common StockSEC:0001856369-26-000005:0
60,000 股0Class A Common StockSEC:0001856369-26-000003:0
40,000 股0Class A Common StockSEC:0001856369-25-000018:0
60,000 股0Class A Common StockSEC:0001856369-25-000016:0
40,390 股@ US$4.141.8% 占其流量Class A Common StockSEC:0001856369-25-000014:0
60,000 股0Class A Common StockSEC:0001856369-25-000012:0
100,000 股0Class A Common StockSEC:0001856369-25-000010:0
120,000 股0Class A Common StockSEC:0001856369-25-000007:0
100,000 股0Class A Common StockSEC:0001856369-25-000005:0
120,000 股0Class A Common StockSEC:0001601830-25-000145:0
100,000 股0Class A Common StockSEC:0001601830-25-000136:0
40,390 股@ US$5.642.4% 占其流量Class A Common StockSEC:0001601830-25-000132:0
423,666 股0Class A Common StockSEC:0001601830-25-000130:0
110 条申报中的 25 条
About Gibson Christopher
Gibson Christopher is Président-Directeur Général and a director of Recursion Pharmaceuticals, INC. and Pacific Biosciences of California, INC., both listed on XNAS. He has 110 filings in total, and across the 110 sampled filings between 2021-12-09 and 2026-05-27, the reported amounts show EUR 0 of buys and EUR 1114641 of sells, with filings of nature C.
